Gary Gellerman

Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells

Kalimuthu Kalishwaralal, Bat-Chen R. Avraham-Lubin, Andrii Bazylevich et al. · Journal of Nanobiotechnology · 2018 · 180 citations · Full text

Toward a PKB Inhibitor:  Modification of a Selective PKA Inhibitor by Rational Design

Hadas Reuveni, Nurit Livnah, Tamar Geiger et al. · Biochemistry · 2002 · 103 citations

A Backbone-Cyclic, Receptor 5-Selective Somatostatin Analogue:  Synthesis, Bioactivity, and Nuclear Magnetic Resonance Conformational Analysis

Chaim Gilon, Martin Huenges, Barbara Mathä et al. · Journal of Medicinal Chemistry · 1998 · 59 citations

Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery

Yossi Gilad, Efrat Noy, Hanoch Senderowitz et al. · Bioorganic & Medicinal Chemistry · 2015 · 53 citations

Biochemistry, Medicine, Peptide Engineering +8

Dual‐drug RGD conjugates provide enhanced cytotoxicity to melanoma and non‐small lung cancer cells

Yossi Gilad, Efrat Noy, Hanoch Senderowitz et al. · Biopolymers · 2015 · 52 citations